Company intelligence / Profile preview

Z33 Bio

Delaware, United States

Ownership: Private
Development stage: Other

Overview

Z33 Bio is a subsidiary entity of Zura Bio created specifically to handle licensing agreements with Eli Lilly. The entity was incorporated to facilitate the in-licensing of therapeutic assets from Eli Lilly for autoimmune disease treatments.

Therapeutic areas: Immunology
Modalities: Monoclonal antibody
Industry: Biotech

Partnerships

Eli Lilly

Beyond the preview

Go deeper on Z33 Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Z33 Bio.

Explore the full profile